Sciecure Pharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCIECURE PHARMA INC, and what generic and branded alternatives to SCIECURE PHARMA INC drugs are available?
SCIECURE PHARMA INC has two approved drugs.
Drugs and US Patents for Sciecure Pharma Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sciecure Pharma Inc | PAROXETINE HYDROCHLORIDE | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209293-003 | Jun 12, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sciecure Pharma Inc | BUDESONIDE | budesonide | CAPSULE, DELAYED RELEASE;ORAL | 209041-001 | Sep 28, 2017 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Sciecure Pharma Inc | PAROXETINE HYDROCHLORIDE | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209293-002 | Jun 12, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.